References
- Leikin J, Vogel S, Graff J, et al. Use of Fab fragments of digoxin-specific antibodies in the therapy of massive digoxin poisoning. Ann Emerg Med 1985; 14: 175–178
- Smith T W, Butler V P, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. N Engl J Med 1982; 307: 1357–1362
- Nollet H, Verhaaren H, Stroobrandt R, Belpaire F. Delayed elimination of digoxin antidatum determined by radioimmunoassay. J Clin Pharmacol 1989; 29: 41–45
- Rainey P. Effects of digoxin immune Fab (ovine) on digoxin immunoassays. Am J Clin Pharmacol 1989; 92: 779–786
- Gibb I, Adams P C, Parnham A J, Jennings K. Plasma digoxin: assay anomalies in Fab-treated patients. Br J Clin Pharmacol 1983; 16: 445–447
- Hansell J R. Effect of therapeutic digoxin antibodies on digoxin assays. Arch Pathol Lab Med 1989; 113: 1259–1262
- Argyle J C. Effect of digoxin antibodies on TDx digoxin assay. Clin Chem 1986; 32: 1616–1617
- Nuwayhid N F, Johnson G F. Digoxin elimination in functionally anephric patient after digoxin-specific Fab fragment therapy. Ther Drug Monit 1989; 11: 680–685
- Clifton G D, McIntyre W J, Zannikos P N, Harrison M R, Chandler M HH. Free and total serum digoxin concentrations in a renal failure patient after treatment with digoxin immune Fab. Clin Pharm 1989; 8: 441–445
- Hursting M J, Raisys V A, Opheim K E, et al. Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose. Clin Chem 1987; 33: 1652–1655
- Lemon M, Andrews D J, Binks A M, Georgiou G A. Concentrations of free serum digoxin after treatment with antibody fragments. Br Med J 1987; 295: 1520–1521
- Csako G. Measurement of pharmacologically active and total digoxin in the presence of Digibind. Clin Chem 1990; 36: 1029
- Schaumann W, Kaufmann B, Neubert P, Smolarz A. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. Eur J Clin Pharmacol 1986; 30: 527–533